Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Method to Extend Research in Time (MERIT) Award (R37)
Project #
4R37CA072614-16
Application #
8111443
Study Section
Special Emphasis Panel (NSS)
Program Officer
Mufson, R Allan
Project Start
1997-02-15
Project End
2017-01-31
Budget Start
2012-02-01
Budget End
2013-01-31
Support Year
16
Fiscal Year
2012
Total Cost
$320,588
Indirect Cost
$113,088
Name
University of California San Francisco
Department
Pediatrics
Type
Schools of Medicine
DUNS #
094878337
City
San Francisco
State
CA
Country
United States
Zip Code
94143
White, Yasmine; Bagchi, Aditi; Van Ziffle, Jessica et al. (2016) KRAS insertion mutations are oncogenic and exhibit distinct functional properties. Nat Commun 7:10647
Zhao, Zhen; Chen, Chi-Chao; Rillahan, Cory D et al. (2015) Cooperative loss of RAS feedback regulation drives myeloid leukemogenesis. Nat Genet 47:539-43
Wong, Jasmine C; Weinfurtner, Kelley M; Alzamora, Maria Del Pilar et al. (2015) Functional evidence implicating chromosome 7q22 haploinsufficiency in myelodysplastic syndrome pathogenesis. Elife 4:
Shannon, Kevin M (2014) CCR4 drives ATLL jail break. J Exp Med 211:2485
Stieglitz, Elliot; Liu, Y Lucy; Emanuel, Peter D et al. (2014) Mutations in GATA2 are rare in juvenile myelomonocytic leukemia. Blood 123:1426-7
Burgess, Michael R; Hwang, Eugene; Firestone, Ari J et al. (2014) Preclinical efficacy of MEK inhibition in Nras-mutant AML. Blood 124:3947-55
North, Matthew; Shuga, Joe; Fromowitz, Michele et al. (2014) Modulation of Ras signaling alters the toxicity of hydroquinone, a benzene metabolite and component of cigarette smoke. BMC Cancer 14:6
Dail, Monique; Wong, Jason; Lawrence, Jessica et al. (2014) Loss of oncogenic Notch1 with resistance to a PI3K inhibitor in T-cell leukaemia. Nature 513:512-6
Sachs, Zohar; LaRue, Rebecca S; Nguyen, Hanh T et al. (2014) NRASG12V oncogene facilitates self-renewal in a murine model of acute myelogenous leukemia. Blood 124:3274-83
Lu, Jing; Zavorotinskaya, Tatiana; Dai, Yumin et al. (2013) Pim2 is required for maintaining multiple myeloma cell growth through modulating TSC2 phosphorylation. Blood 122:1610-20

Showing the most recent 10 out of 39 publications